Search research articles
Contact Us
Filters
Showing results (221-230 of 251) with videos related to
Page
of 26
Sort By:
Cancer Research Communications
|
July 19, 2024
BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer
Hussein Chehade, Radhika Gogoi, Nicholas K Adzibolosu, et al.
Cancer Medicine
|
December 21, 2022
Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study
Susan Eggly, Nicole Senft, Seongho Kim, et al.
Clinical Lung Cancer
|
May 22, 2023
The Role of Surgery in Stage I Small Cell Lung Cancer: A National VA Database Analysis
Ibrahim Azar, Adam Austin, Biplab K Saha, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
JAMA Oncology
|
September 17, 2020
Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer
Nicole Senft, Lauren M Hamel, Mark A Manning, et al.
Ebiomedicine
|
February 18, 2019
Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
Oren Rom, Guan Xu, Yanhong Guo, et al.
Biochemical Pharmacology
|
October 8, 2022
Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia
Katie Hege Hurrish, Xinan Qiao, Xinyu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2018
Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer
Rayna Rosati, Lisa Polin, Charles Ducker, et al.
Scientific Reports
|
July 5, 2022
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment
Adrianne Wallace-Povirk, Lisa Rubinsak, Agnes Malysa, et al.
BMC Cancer
|
December 4, 2017
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
Susan Eggly, Lauren M Hamel, Elisabeth Heath, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 251) with videos related to
Sort By:
Page
of 26
Cancer Research Communications
|
July 19, 2024
BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer
Hussein Chehade, Radhika Gogoi, Nicholas K Adzibolosu, et al.
Cancer Medicine
|
December 21, 2022
Addressing multilevel barriers to clinical trial participation among Black and White men with prostate cancer through the PACCT study
Susan Eggly, Nicole Senft, Seongho Kim, et al.
Clinical Lung Cancer
|
May 22, 2023
The Role of Surgery in Stage I Small Cell Lung Cancer: A National VA Database Analysis
Ibrahim Azar, Adam Austin, Biplab K Saha, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, et al.
JAMA Oncology
|
September 17, 2020
Willingness to Discuss Clinical Trials Among Black vs White Men With Prostate Cancer
Nicole Senft, Lauren M Hamel, Mark A Manning, et al.
Ebiomedicine
|
February 18, 2019
Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
Oren Rom, Guan Xu, Yanhong Guo, et al.
Biochemical Pharmacology
|
October 8, 2022
Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia
Katie Hege Hurrish, Xinan Qiao, Xinyu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2018
Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer
Rayna Rosati, Lisa Polin, Charles Ducker, et al.
Scientific Reports
|
July 5, 2022
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment
Adrianne Wallace-Povirk, Lisa Rubinsak, Agnes Malysa, et al.
BMC Cancer
|
December 4, 2017
Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials
Susan Eggly, Lauren M Hamel, Elisabeth Heath, et al.
Page
of 26